USPH Relative Valuation
USPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, USPH is overvalued; if below, it's undervalued.
Historical Valuation
US Physical Therapy Inc (USPH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 26.72 is considered Undervalued compared with the five-year average of 34.88. The fair price of US Physical Therapy Inc (USPH) is between 83.37 to 104.92 according to relative valuation methord. Compared to the current price of 74.91 USD , US Physical Therapy Inc is Undervalued By 10.14%.
Relative Value
Fair Zone
83.37-104.92
Current Price：74.91
10.14%
Undervalued
27.04
PE
1Y
3Y
5Y
Trailing
Forward
16.67
EV/EBITDA
US Physical Therapy Inc. (USPH) has a current EV/EBITDA of 16.67. The 5-year average EV/EBITDA is 20.79. The thresholds are as follows: Strongly Undervalued below 15.63, Undervalued between 15.63 and 18.21, Fairly Valued between 23.37 and 18.21, Overvalued between 23.37 and 25.95, and Strongly Overvalued above 25.95. The current Forward EV/EBITDA of 16.67 falls within the Undervalued range.
19.96
EV/EBIT
US Physical Therapy Inc. (USPH) has a current EV/EBIT of 19.96. The 5-year average EV/EBIT is 22.68. The thresholds are as follows: Strongly Undervalued below 17.81, Undervalued between 17.81 and 20.24, Fairly Valued between 25.11 and 20.24, Overvalued between 25.11 and 27.55, and Strongly Overvalued above 27.55. The current Forward EV/EBIT of 19.96 falls within the Undervalued range.
1.41
PS
US Physical Therapy Inc. (USPH) has a current PS of 1.41. The 5-year average PS is 2.24. The thresholds are as follows: Strongly Undervalued below 1.22, Undervalued between 1.22 and 1.73, Fairly Valued between 2.75 and 1.73, Overvalued between 2.75 and 3.27, and Strongly Overvalued above 3.27. The current Forward PS of 1.41 falls within the Undervalued range.
14.08
P/OCF
US Physical Therapy Inc. (USPH) has a current P/OCF of 14.08. The 5-year average P/OCF is 17.36. The thresholds are as follows: Strongly Undervalued below 10.92, Undervalued between 10.92 and 14.14, Fairly Valued between 20.58 and 14.14, Overvalued between 20.58 and 23.81, and Strongly Overvalued above 23.81. The current Forward P/OCF of 14.08 falls within the Undervalued range.
16.85
P/FCF
US Physical Therapy Inc. (USPH) has a current P/FCF of 16.85. The 5-year average P/FCF is 21.44. The thresholds are as follows: Strongly Undervalued below 11.24, Undervalued between 11.24 and 16.34, Fairly Valued between 26.55 and 16.34, Overvalued between 26.55 and 31.65, and Strongly Overvalued above 31.65. The current Forward P/FCF of 16.85 falls within the Historic Trend Line -Fairly Valued range.
US Physical Therapy Inc (USPH) has a current Price-to-Book (P/B) ratio of 2.28. Compared to its 3-year average P/B ratio of 3.02 , the current P/B ratio is approximately -24.72% higher. Relative to its 5-year average P/B ratio of 3.70, the current P/B ratio is about -38.53% higher. US Physical Therapy Inc (USPH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 4.68%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 4.97% , the current FCF yield is about -100.00% lower.
2.30
P/B
Median3y
3.02
Median5y
3.70
4.96
FCF Yield
Median3y
4.68
Median5y
4.97
Competitors Valuation Multiple
The average P/S ratio for USPH's competitors is , providing a benchmark for relative valuation. US Physical Therapy Inc Corp (USPH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 17.32%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of USPH decreased by 13.99% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 5.82 to 8.95.
The secondary factor is the Revenue Growth, contributed 17.32%to the performance.
Overall, the performance of USPH in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is US Physical Therapy Inc (USPH) currently overvalued or undervalued?
What is US Physical Therapy Inc (USPH) fair value?
How does USPH's valuation metrics compare to the industry average?
What is the current P/B ratio for US Physical Therapy Inc (USPH) as of Dec 05 2025?
What is the current FCF Yield for US Physical Therapy Inc (USPH) as of Dec 05 2025?
What is the current Forward P/E ratio for US Physical Therapy Inc (USPH) as of Dec 05 2025?